Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
HDFC Pharma and Healthcare Fund Reg (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 04-Oct-23
Corpus(Cr.) 3501.00 Latest NAV 21.083 As on 29-10-2026
Equity(%) 96.77 52 Week High 22.101
Debt(%) 3.23 52 Week Low 16.364
Others(%) 0.00 Exit Load 1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Nikhil Mathur
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 31.13%
Top 10 Holdings 49.19%
Top 25 Holdings 86.93%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 71.27
Healthcare 24.49
Cash 3.23
Retail 1.01
 
 
 
 
 
Portfolio Metrics
PB Ratio 6.27
PE Ratio 48.47
 
Top 25 Holdings
Holdings Net Asset(%)
Divis Laboratories Ltd. 9.39
Sun Pharmaceutical Industries Ltd. 8.28
TREPS - Tri-party Repo 4.67
Alkem Laboratories Limited 4.64
Cipla Ltd. 4.15
Apollo Hospitals Enterprises Ltd. 3.69
Torrent Pharmaceuticals Ltd. 3.65
Max Healthcare Institute Limited 3.61
Aster DM Healthcare Limited 3.56
Lupin Ltd 3.55
Neuland Laboratories Limited. 3.24
Shilpa Medicare Ltd. 3.23
Dr. Reddys Laboratories Ltd. 3.19
ACUTAAS CHEMICALS LIMITED 3.18
Anthem Biosciences Limited 3.17
Ipca Laboratories Ltd. 2.98
Global Health Limited 2.72
RUBICON RESEARCH LIMITED 2.52
Krishna Institute of Medical Sciences Limited 2.10
Glenmark Pharmaceuticals ltd 2.09
Molbio Diagnostics Limited 2.01
Vijaya Diagnostic Centre Limited 2.00
Zydus Lifesciences Limited 1.82
Gland Pharma Limited 1.78
Wockhardt Ltd 1.71

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-2.45% -0.16% 15.57% 21.28%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
-2.23% -2.98% 8.71% 8.99%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
14.86% 28.88% 0.00% 0.00%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
6.75% 21.05% 14.18% 10.60%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
HDFC Pharma and Healthcare Fund Reg (G) 0.00% 0.0000 0.0000% 0.0000 0.0000
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
HDFC Pharma and Healthcare Fund Reg (G) 0.0000% 0.0000 0.0000 0.0000 0.0000
 
Back to Selection